Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benzoyl-tyrosyl-paba
2. N-benzoyl-l-tyrosyl-p-aminobenzoic Acid
3. N-benzoyl-l-tyrosyl-paba
4. Paba-peptide
1. 37106-97-1
2. Btpaba
3. Chymex
4. Bz-tyr-4-abz-oh
5. Bentiromido
6. Bentiromidum
7. Btpaba, Pft
8. Btpaba Pft
9. Bentiromidum [inn-latin]
10. Bentiromido [inn-spanish]
11. Btpabapft
12. Btpaba-pft
13. Benzoyltyrosyl-p-aminobenzoic Acid
14. E-2663
15. Pft
16. Chebi:31263
17. 239if5w61j
18. N-benzoyl-l-tyrosyl-p-aminobenzoic Acid
19. (s)-p-(alpha-benzamido-p-hydroxyhydrocinnamamido)benzoic Acid
20. 4-(n-benzoyl-l-tyrosyl)aminobenzoic Acid
21. 4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic Acid
22. (s)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic Acid
23. 4-[(2s)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic Acid
24. Benzoic Acid, 4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)-, (s)-
25. P-((n-benzoyl-l-tyrosin)amido)benzoic Acid
26. Brn 2910938
27. Ro 11-7891
28. Unii-239if5w61j
29. 4-((2-(benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic Acid
30. Bentiromide [usan:ban:inn:jan]
31. Bentiromide [usan:inn:ban:jan]
32. Einecs 253-349-8
33. Bt-paba
34. Bentiromide [mi]
35. Bentiromide [inn]
36. Bentiromide [jan]
37. Bentiromide [usan]
38. Bentiromide [vandf]
39. E 2663
40. Bentiromide [mart.]
41. Bentiromide [who-dd]
42. (s)-p-(.alpha.-benzamido-p-hydroxyhydrocinnamamido)benzoic Acid
43. Schembl151634
44. Chembl1200368
45. Dtxsid2048377
46. Bentiromide [orange Book]
47. Zinc608204
48. Hy-b1493
49. N-benzoyl-l-tyrosyl-p-aminobenzoate
50. Mfcd00055768
51. S4388
52. Ccg-268691
53. Db00522
54. 4-(n-benzoyl-l-tyrosyl)aminobenzoicacid
55. 4-(n-benzoyl-l-tyrosylamino)benzoic Acid
56. 4-[(n-benzoyl-l-tyrosyl)amino]benzoic Acid
57. Cs-0013190
58. Sw219774-1
59. Ab01566933_01
60. 106b971
61. Q793082
62. Sr-01000883958
63. Sr-01000883958-1
64. (s)-4-(2-benzamido-3-(4-hydroxyphenyl)propanamido)benzoic Acid
65. (4-[[(2s)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic Acid
Molecular Weight | 404.4 g/mol |
---|---|
Molecular Formula | C23H20N2O5 |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 404.13722174 g/mol |
Monoisotopic Mass | 404.13722174 g/mol |
Topological Polar Surface Area | 116 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 588 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Indicated as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy.
Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. The amount of p-aminobenzoic acid and its metabolites excreted in the urine is the quantitative measure of the chymotrypsin-secreting activity of the pancreas.
Indicators and Reagents
Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh's Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CK - Tests for pancreatic function
V04CK03 - Bentiromide
Primarily hepatic. Enzymatic activity capable of hydrolyzing bentiromide has also been found in normal small intestine.
Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. By determining the output of unchanged bentiromide in the urine following oral administration, it is possible to determine the sufficiency of pancreatic activity.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?